Citation

Ishichi Y, Kimura E, Honda E, Yoshikawa M, Nakahata T, Terao Y, Suzuki A, Kawai T, Arakawa Y, Ohta H, Kanzaki N, Nakagawa H, Terauchi J.: Novel triple reuptake inhibitors with low risk of CAD associated liabilities: design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds. Bioorg Med Chem, Volume 21 (15), 2013

Authors

Arakawa Y, Honda E, Ishichi Y, Kanzaki N, Kawai T, Kimura E, Nakagawa H, Nakahata T, Ohta H, Suzuki A, Terao Y, Terauchi J., Yoshikawa M

Journal

Bioorg Med Chem

Year

2013

DOI

10.1016/j.bmc.2013.05.025

PubMed

23769168

Machine-readable

REST APIRDF